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INTRODUCTION 
Human papillomaviruses (HPVs) are prevalent pathogens that infect either 
mucosal or cutaneous epithelium. Most infections are asymptomatic; however, 
a small fraction lead to hyperproliferative lesions, such as warts and condyloma, 
or in the case of high-risk human papillomaviruses, to malignant tumors. As a 
result, HPVs are the major cause of cervical cancer (zur Hausen 2002). 
Cervical cancer is the third most common cancer worldwide (Jemal et al. 
2011), and HPVs are the etiologic agent of 5% of all lethal cases of cancer 
worldwide. In addition, a major proportion of anal, perianal, vulvar, and penile 
cancers appear to be primarily linked to HPVs. Moreover, papillomavirus 
infection has also been identified in non-genital cancers, including lung, colon, 
esophageal, laryngeal, oropharyngeal and urothelial cancers (Mammas et al. 
2011). Thus, great effort needs to be put into patient screening, vaccine 
development, and therapeutic strategies. 
Our research group has focused on understanding what happens to HPV 
genomes after transfecting them into the nucleus of U2OS cells, including 
revealing the mechanism(s) behind the formation of genomic oligomers and 
analyzing an unidentified replication mechanism that functions in addition to 
the well-documented theta type of bidirectional replication. 
One of the best methods for analyzing replication intermediates (RIs) of the 
HPV genome is two-dimensional agarose gel electrophoresis (2D AGE). This 
method provides clear visualization of molecules of different structures and 
sizes. However, it is also difficult and time-consuming to perform and provides 
results that are even more difficult to interpret. Therefore, in the interest of 
reproducibility, I have included an overview of various applications of these 
methods, together with an analysis of the results. 
Based on results obtained from 2D assays, we have identified the oligomeric 
















Human papillomaviruses are a large family of small double-stranded DNA vi-
ruses that infect basal keratinocytes in stratified epithelia. Papillomaviruses 
(PVs) are extremely species and tissue specific; they only infect the keratino-
cytes of amniotes (mammals, birds, and reptiles) (Bernard et al. 2010; Rector 
and Van Ranst 2013). 
Human papillomaviruses commonly cause cutaneous and genital warts, less 
commonly anogenital cancers, oropharyngeal cancer, and recurrent respiratory 
papillomatosis. Evidence suggests that different types of HPVs have existed 
since the evolutionary origin of humans (Bernard et al. 2006; Chen et al. 2009); 





PVs have maintained their basic genomic organization for more than 100 mil-
lion years. The PV genome is composed of genetically stable double-stranded 
DNA that is replicated by the host cell's DNA replication machinery. Diversifi-
cation of PV genomes has occurred at a low evolutionary rate due to slow DNA 
replication, the proofreading abilities of DNA polymerases and the absence of 
intra-type recombination (Bernard et al. 2006).  
To date, more than 300 PVs have been identified and completely se-











Figure 1. Schematic representation of HPV18 virion. Blue pentagons represent major 
capsid protein L1 and yellow circles represent minor capsid protein L2. The HPV18 





The HPV genome consists of an approximately 6–8 kbp long circular double-
stranded DNA (dsDNA). All HPVs have the same general organization of their 
genome, which can be functionally divided into three general components – a 
noncoding upstream regulatory region (URR), an early (E) region, and a late (L) 
region (Fig. 1, HPV18 genome inside the virion). 
The 400–1000 bp long URR region contains the viral origin of replication, 
binding sites for viral and host regulatory proteins, early promoter, enhancer, 
and silencer sequences that work together to control transcription from the early 
open reading frames (ORFs), viral DNA amplification, and cellular tropism 
(reviewed in (Longworth and Laimins 2004)). The early region carries ORFs 
for non-structural regulatory proteins E1, E2, E4, E5, E6, and E7 (E5, E6 and 
E7 are not universally present in all PV types), which function to adapt viral 
activities to changes in the cellular milieu, regulate viral genome replication, 
cell cycle control, viral transcription, cellular transformation and proliferation, 
elude the host immune system, and modify the host cell to facilitate the release 
of progeny virions (reviewed in (Longworth and Laimins 2004; Egawa et al. 
2015)). Additional early proteins have also been identified (E3, E8); however, 
their expression is not uniform throughout the Papillomaviridae family (Harari 
et al. 2014).  
The late region carries ORFs for the structural major and minor capsid 
proteins, L1 and L2, respectively, which form the icosahedral viral capsid 
((Doorbar and Gallimore 1987), reviewed in (Buck et al. 2013; Wang and 
Roden 2013)). Late transcripts, including E1^E4, are initiated by a late pro-
moter located in the E7 ORF (del Mar Pena and Laimins 2001). 
 
 
Viral early proteins 
HPV proteins E1 and E2, together with the host replication machinery, are 
necessary and sufficient to replicate the papillomavirus genome (Ustav and 
Stenlund 1991; Chiang et al. 1992; Sverdrup and Khan 1994). E1 harbors 
ATPase activity while it melts dsDNA for strand separation. It thus works as a 
helicase and participates in recruiting host DNA replication factors to the viral 
origin of replication (Seo et al. 1993b; Park et al. 1994; Han et al. 1999; Berg-
vall et al. 2013). E2 functions in viral transcription and viral DNA replication 
and plays a role in viral genome partitioning (reviewed in (McBride 2013)). 
Viral DNA replication is initiated when a dimeric E1 protein attaches to its 
binding site with the help of a dimeric E2 protein. E2 protein increases the 
affinity and site-specificity of E1 protein (Seo et al. 1993a). As a result, more 
E1 proteins are recruited, followed by the release of E2 proteins from the accu-
mulated complex, thereby resulting in the formation of a double hexamer E1 
protein complex, which starts to unwind the dsDNA (Sedman and Stenlund 
1998; Auster and Joshua-Tor 2004).  
E2 protein is responsible for recruiting cellular factors to the viral genome, 
which in turn regulate transcriptional processes. E2 is also responsible for the 
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down-regulation of early promoter activity to maintain a low profile during the 
early stages of the viral life cycle. This role is supported by the fact that HPV 
integration into the host genome often results in disruption of the E2 ORF, 
which in turn dismisses early promoter regulation and thereby avoids over-
expression of E6 and E7 (Hegde 2002; Longworth and Laimins 2004; Doorbar 
2006). In HPV associated cancers, continued expression of E6 and E7 sustains 
the continued cancer phenotype, whereas the late genes are not expressed and 
progeny viruses are not produced (Stoler et al. 1992; Chow and Broker 2013). 
E1 has also been shown to function in early induction of the DNA damage 
response (DDR) pathway, which in turn facilitates a permissive environment for 
viral genome replication. E1 is capable of inducing breaks in the host dsDNA 
signals cell cycle arrest (Fradet-Turcotte et al. 2011; Sakakibara et al. 2011; 
Reinson et al. 2013).  
E5, E6, and E7 stimulate cell proliferation and cell survival and modulate 
keratinocyte differentiation. The E5 ORF encodes a transmembrane protein that 
most likely contributes to cell signaling (Chen and Mounts 1990). Because HPV 
heavily relies on cellular proteins for its genome replication and transcription, 
the essential role of E6 and E7 in the viral life cycle is primarily to modify the 
cellular environment to permit viral genome amplification, which mainly occurs 
by driving S-phase re-entry in the upper epithelial layers.  
E6 and E7 play different roles in high- and low-risk HPVs. In the case of 
high-risk types, E6 and E7 function as oncogenes by disrupting pathways cont-
rolled by the two major tumor suppressors, p53 and the pRB family of proteins, 
and additional host proteins, as well as driving cell proliferation in the basal 
layers ((Doorbar 2006; McLaughlin-Drubin and Munger 2009; Chow and 
Broker 2013), reviewed in (Moody and Laimins 2010)). However, in low-risk 
types, the role that these proteins play is unclear (reviewed in (Roman and 
Munger 2013; Vande Pol and Klingelhutz 2013)). Differences in the function of 
E6 and E7 represent a major determinant of HPV disease pathogenicity between 
HPV types (White and Howley 2013). 
During the HPV life cycle, E4 is first synthesized as part of the E1^E4 
fusion protein from spliced E1^E4 transcripts, where the first few amino acids 
contain the N terminus of E1 (Nasseri et al. 1987). E4 protein accumulates 
massively in the upper epithelial layers, where viral genomes are packaged into 
virus particles (Doorbar 2013). E4 protein optimizes viral genome amplification 
and participates in viral release (Egawa et al. 2017). In high-risk HPV types, E4 
protein assembles into amyloid fibrils that can disrupt the structure of keratin 
and compromise the normal assembly of the cornified envelope. It has been 
suggested that E4 amyloid fibers may contribute to virion release from the 
epithelial surface, and as a result, they may influence both infectivity and trans-
mission (McIntosh et al. 2008; McIntosh et al. 2010). However, E4 probably 
does not have precisely the same function in all papillomaviruses (Egawa et al. 
2017). 
that activate the ATM (ataxia-telangiectasia mutated) DDR pathway, which 
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Life cycle of stratified squamous epithelial cells 
Epithelial tissue is a multi-layered structure in which each stratum has a certain 
gene expression pattern and cellular architecture. Therefore, the epithelium is 
comprised of keratinocytes at various stages of differentiation. Only basal cells 
are mitotically active in healthy epithelial tissues (Chow et al. 2010). As basal 
cells divide, one daughter cell retains its position in the basement layer and the 
ability to propagate. The other daughter cell is pushed upward from the basement 
layer, after which its gene expression pattern is altered; the cell starts to diffe-
rentiate, exits the cell cycle, and loses its ability to propagate (Fig. 2, cells with 
black lines). 
During the differentiation of keratinocytes, keratin is synthesized to 
strengthen the cytoskeleton. The final stage of this differentiation program is the 
built-in program of apoptosis of the keratinocytes. The normal life cycle of 
epithelial cells lasts about three weeks with the final step being the release of 
necrotic keratinocytes from the epithelial surface (Fuchs 2008; Fuchs 2009). 
 
 
Papillomavirus life cycle 
The life cycle of HPV is closely related to the stages of differentiation within 
the host epithelium. As mentioned above, HPVs are highly tissue specific and 
infect only mucosal or cutaneous epithelial cells. For a successful infection, 
HPVs must enter dividing basal cells of the epithelium and connect their life 
and replication cycle with the host cell differentiation program (reviewed in 
(Doorbar et al. 2012)). 
The viral life cycle is closely related to the viral replication cycle; both can 
be separated into three phases. An initial amplification phase (also known as 
transient viral DNA replication) occurs first, after the HPV has entered the 
basement membrane of either the mucosal or squamous epithelium via an 
injury. Replication of viral DNA starts in the host cell nucleus and continues 
until the copy number of HPV genomes is high. In the second phase, the viral 
DNA copy number is held at a constant level in proliferative basal epithelial 
cells and thus is termed the stable maintenance phase (latent infection). The 
third phase occurs when the infected cells are pushed upwards from the basal 
layer and start to differentiate. The virus prevents the cells from concluding 
their life cycle, and infected cells aberrantly re-enter the cell cycle and begin to 
amplify HPV genomes to an even higher copy number. The final phase is 
termed the second amplification (also known as late or vegetative amplifi-
cation). As the infected cells move towards the surface of the stratified epithe-
lium, they express late capsid proteins and viral DNA is packed into progeny 
virions (Fig. 2, cells with red lines, virions are marked with purple hexagons). 
These infectious virions are then released from the surface of the epithelium 






Figure 2. Schematic representation of asymptomatic and infected epithelium. In a 
normal epithelium, only basal cells are capable of dividing and replicating. After cell 
division, one cell is pushed upward from the basement layer and begins to differentiate; 
it loses its ability to replicate and is finally shed form epithelium. Infected basal cells, 
however, maintain their replicative capability even after being pushed from the base-
ment layer. After infection with HPV, initial amplification occurs, which is followed by 
a stable maintenance phase. After leaving the basement layer, the second amplification 
phase begins. HPV produces virions in the uppermost layers of the epithelium, and they 
are finally shed from the epithelial surface. Figure adapted from (Henno et al. 2017). 
 
 
It has been proposed that after virions enter the basal cells and amplify their ge-
nome, the latent persistence of HPV DNA is established. However, if infection 
only occurs in cells that have already started their differentiation program, only 
short-term infection is established because these HPVs are eliminated along 
with the shedding cells that have finished their normal differentiation program 
(reviewed in (Bodily and Laimins 2011)). 
 
 
Initial amplification of HPV genome 
An injury enables HPV virions to attach to the basal keratinocytes within either 
the mucosal or squamous epithelium. After HPV virions enter the cell, the ge-
nome is unpacked and transported to the nucleus. The mechanism of viral at-
tachment and entrance into the host cell is still not precisely known; however, 
several cellular and viral proteins have been proposed to be involved in the pro-
cess. Heparin sulfate has been proposed as one possible cellular receptor, and L1 
and L2 proteins ensure the infectiveness of HPV virions (Joyce et al. 1999; 
Horvath et al. 2010). Once in the nucleus, early proteins are expressed from the 
early promoter and the HPV genome copy number is amplified to ensure a per-
sistent infection. Rapid amplification is achieved by replicating HPV DNA 
repeatedly during one cell cycle of these host cells ((Demeret et al. 1997; Steger 
and Corbach 1997), reviewed in (Kadaja et al. 2009; Moody and Laimins 2010)).  
It is difficult to study the life cycle of PVs under laboratory conditions. Nev-
ertheless, the initial amplification can be mimicked by transfecting eukaryotic 
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cells with HPV genomes; however, only a few cell lines are capable of sup-
porting papillomavirus DNA replication. We utilize our U2OS cell line based 
model system to mimic HPV genome replication cycles (Geimanen et al. 2011). 
Our experiments on HPV DNA replication are performed during the initial short 
establishment period by transfecting the U2OS cells with HPV genomes and 
analyzing the extracted episomal DNA 3 to 5 days after transfection (Orav et al. 
2013; Orav et al. 2015; Henno et al. 2017). 
 
 
Stable maintenance replication of HPV genome 
After the initial amplification of viral DNA, the genome copy number is held at 
a constant level. HPV DNA replication occurs at the same rate as host genome 
replication. During the latent phase, the necessary proteins for episomal mainte-
nance are expressed at low levels, which presumably occurs to evade detection 
by the host immune system (reviewed in (Stanley 2012)).  
PV replication occurs, on average, once during the cell cycle, concurrently 
with host replication, and viral genomes are divided almost equally between the 
daughter nuclei (reviewed in (McBride et al. 2006; Kadaja et al. 2009; Bodily 
and Laimins 2011)). This observation could mean that either PV replicates in a 
strictly once-per-S-phase mode (Roberts and Weintraub 1988; Kim and 
Lambert 2002) or at random modes, where some cells replicate several times 
during the host cell cycle and others may not replicate at all (Gilbert and Cohen 
1987; Ravnan et al. 1992; Piirsoo et al. 1996). It has been shown that PV 
genomes are capable of both replication modes during the stable maintenance 
phase, depending on the cell type that carries the viral episomes or on the 
amount of E1 protein in the host cells ((Hoffmann et al. 2006), reviewed in 
(Kadaja et al. 2009)). 
Cells that support stable replication of HPV can be obtained from cervical 
lesions (Hoffmann et al. 2006) or they can be created by transfecting cells 
capable of supporting HPV DNA replication with HPV genomes and cultivating 
HPV-positive cells under regular culture conditions (Geimanen et al. 2011).  
 
 
Vegetative amplification of HPV genome 
When normal, uninfected stratified squamous epithelial cells are pushed from 
the basement membrane, they start to differentiate and exit the cell cycle; how-
ever, HPV needs the cells to be mitotically active to continue its life cycle with 
a supply of necessary cellular DNA polymerases and replication factors that are 
only produced in mitotically active host cells. If the HPV-infected host cell is 
pushed upwards from the basal cell layer, the HPV replication cycle continues. 
This continuation is achieved through the action of viral oncoproteins that 
modify the cellular checkpoint mechanisms so that the cell cycle remains active 
and an unscheduled re-entry into the S-phase occurs without the induction of 
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cell apoptosis, which enables the virus to utilize the proteins necessary for host 
cell replication. However, it has been shown that the virus replicates its DNA 
also during the G2 phase, after host cell replication (Banerjee et al. 2011), 
which implies that HPV utilizes other means to obtain the necessary machinery 
to replicate its DNA. Therefore, it has been proposed that HPV induces and 
uses DDR pathways for replicating viral genomes in the G2 phase (Moody and 
Laimins 2009; Fradet-Turcotte et al. 2011; Gillespie et al. 2012; Reinson et al. 
2013). DDR is also induced during the replication of other viruses, such as 
adenovirus, herpes simplex virus type 1 (HSV-1), Epstein-Barr virus (EBV), 
polyomavirus, SV40, and minute virus of canines, because viral DNA and repli-
cation intermediates (RIs) are sensed by the host as damaged DNA (Stracker et 
al. 2002; Dahl et al. 2005; Lilley et al. 2005; Shi et al. 2005; Luo et al. 2011). 
When HPV-positive cells reach the spinous layer, viral replication proteins 
are expressed at a much higher rate. Therefore, the viral DNA copy number in-
creases and this step is called second amplification (reviewed in (Bodily and 
Laimins 2011)). Lastly, in the upper layers of the epithelium, amplified viral ge-
nomes are packaged into viral particles produced from the major (L1) and minor 
(L2) virus late coat proteins. Because late proteins induce a strong immune 
response, their expression is delayed until the infected cell reaches the upper 
epithelial layer. As E1^E4 protein constructs induce the collapse and apoptosis 
of differentiated host cells in the uppermost layers of the epithelium, they play an 
important role in the detachment of viral particles (Nakahara et al. 2005). Virions 
only detach from the upper epithelial layer when the host cells are almost 
collapsed because papillomaviruses are not lytic, which is another reason to 
avoid the immune response of the host organism (reviewed in (Bodily and 
Laimins 2011)). 
Second amplification can be mimicked in vitro by cultivating HPV-positive 
keratinocyte cell lines in methylcellulose (Green 1977), a high-calcium medium 
(Boyce and Ham 1983; Berghard et al. 1990) or high cell confluence (Poumay 
and Pittelkow 1995; Minner and Poumay 2009). Organotypic raft cultures of 
keratinocytes are capable of supporting the entire life cycle of HPVs (Dollard et 
al. 1992; Cheng et al. 1995; Flores et al. 1999; Fehrmann et al. 2003). 
 
 
New model system to study HPV genome replication  
Several cellular systems that mimic layered epithelial structures have been 
created to study HPV genome replication mechanisms. With the aid of these 
systems, one can follow and analyze viral genome replication in both basal and 
differentiated cells. The most suitable cellular system for mimicking HPV 
replication cycles utilizes primary foreskin or cervical keratinocytes, which can 
reconstruct the viral life cycle in raft cultures when transfected with high-risk 
HPV genomes (Chow et al. 2010). Though, experiments that utilize this kind of 
system are labor-intensive, expensive, and complicated. However, less 
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complicated systems, such as monolayer cultures of human transformed cell 
lines, cannot successfully mimic the entire HPV life cycle. 
Our research group at the Institute of Technology within Tartu University 
has developed a novel model system that is based on transfecting viral genomes 
into U2OS cells (Geimanen et al. 2011). These cells provide efficient 
replication of not only high-risk HPVs (HPV16, HPV18) but also low-risk 
(HPV11, HPV6b) and cutaneous HPVs (HPV5, HPV8, HPV38). In addition, 
this model system can mimic the transient, stable, and vegetative phases of the 
HPV replication cycle. The U2OS model system is less labor-intensive, 
cheaper, and easier to use compared with other model systems (Geimanen et al. 
2011). 
Because HPV genomes exist in nuclei as covalently closed circular plasmids 
(episomal molecules), we conduct our experiments using similar, but bacterially 
grown, minicircle genomes (Kay et al. 2010; Henno et al. 2017). The 
transcription pattern of HPV18, HPV11, and HPV5 genome replication in 
U2OS cells is identical to the pattern of transcription in keratinocytes (Wang et 
al. 2011; Sankovski et al. 2014; Toots et al. 2014; Isok-Paas et al. 2015). This 
result gives us confidence that our model system mimics the initial transient, 
stable maintenance, and vegetative amplification replication phases of HPVs. 
 
 
The role of oligomers in the HPV replication cycle 
Using our model system, which is based on transfecting different HPVs into 
U2OS cells, we are able to identify linked molecules that consist of several 
HPV genomic copies – oligomers (also known as multimers) from extracted 
HPV DNA. HPV genomic oligomers contain several viral genomes in a head-
to-tail orientation (Geimanen et al. 2011; Orav et al. 2013). HPV genomes 
begin to generate oligomers as soon as 24 h post transfection, and the propor-
tion of monomers and multimers shifts over time such that the number of oligo-
mers increases (Geimanen et al. 2011; Orav et al. 2013).  
Studies performed in HPV-positive U2OS cell lines that mimic the stable 
phase of replication show that HPV genomes only exist in them as oligomers 
(Geimanen et al. 2011). We propose that these oligomers have only one active 
origin and can therefore replicate several genomes while utilizing only one 
replication complex. This arrangement enables HPV to maintain a large number 
of viral genomes while using a small number of host and viral proteins. The 
phenomenon of utilizing one active origin in an oligomer has been shown in 





Figure 3. Schematic representation of oligomers that consist of HPV monomers in 
head-to-tail orientation. Each HPV monomer consists of one genome and one origin 




We propose that oligomer generation is dependent on homologous recombi-
nation (HR) related processes (Orav et al. 2013). The results and discussion 
section of this dissertation provides further insights into the mechanism of HPV 
genome replication and oligomer generation and the possibility of one active 
origin in an oligomer. The next section provides an overview of the various 
mechanisms proposed for HPV DNA replication. 
 
 
Mechanisms proposed for circular DNA replication 
Several different mechanisms have been proposed for circular DNA replication, 
some of which can also be related to PV DNA replication. This section presents 





Figure 4. Five different kinds of mechanisms of circular dsDNA replication. A) 
Rolling circle replication of bacterial plasmids is initiated when a sequence-specific 
ssDNA break is introduced into the dsDNA origin, the double helix is unwound and 
elongation of the 3’ strand occurs in a way that the non-template single strand is dis-
placed. The ssDNA then acts as a template for synthesis of the lagging strand. Okazaki 
fragments are indicated with a fragmented line on the lagging strand. B) Rolling circle 
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replication of bacteriophage λ results in RIs with long tails of linear concatemeric λ 
DNA. Okazaki fragments are indicated with a fragmented line on the lagging strand. C) 
Bidirectional theta replication is initiated at the origin of replication. Two replication 
forks progress until they meet opposite of the origin. This meeting results in the separa-
tion of dsDNA daughter molecules. D) In unidirectional replication, a single replication 
fork progresses in one direction until it reaches the initiation site, which results in the 
separation of dsDNA daughter molecules. E) The likely mechanism for recombination 
dependent replication and the generation of oligomeric circular molecules of HPV.  
 
 
Rolling circle replication 
Rolling circle replication (RCR) is a replication mechanism adopted by several 
organisms as it is the simplest to initiate. RCR of bacterial plasmids is initiated 
by a sequence-specific nick in the dsDNA origin (Fig. 4A, marked with a red 
square), which generates a primer (3’ DNA) for leading-strand initiation and a 
priming site for lagging-strand synthesis. The 3’ DNA end is then extended by a 
DNA polymerase. Elongation of the leading strand occurs as the double helix is 
unwound and the non-template DNA strand is simultaneously displaced. 
Termination of a round of leading-strand replication occurs when it reaches the 
nick site, which is followed by cleaving of the new molecule and release of the 
non-template ssDNA. This single strand then serves as a template for synthesis 
of a lagging strand ((del Solar et al. 1998), reviewed in (Khan 2005; Ruiz-Maso 
et al. 2015)). A schematic representation of circular dsDNA RCR of a bacterial 
plasmid is provided in Fig. 4A. 
RCR of bacteriophage λ has been shown to occur after bidirectional theta 
replication, and the resulting intermediates have concatemeric linear tails; thus, 
these RIs resemble the Greek letter σ (Skalka et al. 1972; Bastia and Sueoka 
1975). Therefore, it is also termed both sigma and late replication. Regulation 
of the switch from theta to sigma replication of λ DNA remains unknown. 
Sigma type RCR replication produces concatemeric molecules that are several λ 
DNA units long (Taylor and Wegrzyn 1995). These long linear multi-genome 
length RCR sigma replication products are then cut at specific sites, and it is 
possible that the resulting dsDNA breaks (DSBs) become the entry sites for 
recombination (reviewed in (Szczepanska 2009)). A schematic representation of 
circular dsDNA RCR of bacteriophage λ is provided in Fig. 4B. 
 
 
Bidirectional theta replication 
Bidirectional theta replication is initiated at the origin of replication. Two 
replication forks assemble at the origin and progress in opposite directions until 
they meet opposite of the origin (termination of replication). In Fig. 4C, the 
origin is marked with a red square and termination is marked with a black 
square. After the replication forks have converged, the replicating molecule is 
separated into circular dsDNA daughter molecules. A schematic representation 
of bidirectional theta replication is provided in Fig. 4C.  
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Unidirectional replication 
Unidirectional replication proposed for HPV may (Yang and Botchan 1990) or 
may not (Orav et al. 2015) have a specific initiation site. One replication fork 
progresses around the circular genome in a unidirectional manner until it 
reaches the initiation site, therefore, one of the two ends of the replication eye is 
stationary and the other moves with replication. A schematic representation of 
unidirectional replication is depicted in Fig. 4D.  
 
 
Recombination dependent replication 
Recombination dependent replication (RDR) has distinct special characteristics 
in different organisms. The initiation of RDR is similar to the initiation of HR, 
which leads to the synthesis of a minimal amount of DNA necessary for dsDNA 
break repair; however, RDR leads to the replication of extensive DNA se-
quences (Malkova and Ira 2013). In phage SSP1 with circular dsDNA genome, 
replication is initiated by the theta mode (circle-to-circle); but, after at least one 
round of replication, a switch to the σ type of RDR occurs in which the gener-
ated DSBs may trigger RDR at different locations (reviewed in (Flores et al. 
1999)). RDR has been shown to be necessary to produce a high yield of DNA 
(Taylor and Wegrzyn 1995). Initiation by theta replication, followed by RDR, 
might be a characteristic replication mechanism in not only SPP1 and many 
other phages but also HSV-1 (Skalka 1977; Strang and Stow 2005; Shutt and 
Gray 2006; Szczepanska 2009). However, the exact mechanism determining 
when and how RDR is used to replicate viral DNA remains to be elucidated 
(reviewed in (Lo Piano et al. 2011)). A schematic representation of RDR is 
provided in Fig. 4E. RDR has many similar characteristics to break-induced 
replication (BIR), which is a pathway of HR. BIR contributes to the repair of 
broken replication forks and is initiated by invasion of a ssDNA into a homolo-
gous DNA molecule, resulting in the formation of a D-loop. This step is fol-
lowed by extension of DNA synthesis. 
Various replication mechanisms have been proposed to occur in different 
stages of the HPV life cycle, yet some are inconclusive and possibly even con-
trary. It has previously been shown that PVs use bidirectional replication during 
initial amplification and at least to some extent during the stable maintenance 
phase of viral DNA replication (Schvartzman et al. 1990; Flores and Lambert 
1997). Data obtained from the second amplification phase is, however, 
inconclusive because it is suggested in (Auborn et al. 1994) that bidirectional 
replication is involved in the vegetative amplification replication of PV ge-
nomes, yet (Flores and Lambert 1997) proposes that RCR is the mechanism 
used in this phase. It has also been suggested that HPV is replicated in differen-
tiated cells by RDR, which is supported by the induction and activation of HR-
related DDR pathways (Sakakibara et al. 2013; Gautam and Moody 2016).  
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Our understanding from the experiments conducted in the U2OS cell-line 
with HPV18 genomes during the initial amplification phase confirm the occur-
rence of bidirectional theta replication. However, we cannot see the presence of 
RIs from rolling circle replication and our results suggest the involvement of 
another mode, possibly RDR, during the initial amplification phase (Orav et al. 
2013; Orav et al. 2015). The key to understanding the mode of HPV DNA 
synthesis is understanding the structures of replicating molecules, and for this 
purpose, 2D AGE is one of the best methods of characterizing the RIs that are 
generated during the replication of HPV genomes.  
 
 
DNA damage response 
DNA damage lesions are a natural part of a cell’s life, and their causes can be 
either endogenous or exogenous. Endogenous damage is caused by replication 
errors, unrepaired single-strand lesions, base deamination, or loss. Environmen-
tal lesions are caused by exposure to ultraviolet, infrared, reactive oxygen spe-
cies, S-adenosyl methionine, dietary nitrosamines, and tobacco smoke. For a 
normal life cycle of a cell, cellular DNA must defy these internal and external 
agents, which can cause single- and/or double-strand DNA breaks, DNA muta-
tions and crosslinking, formation of pyrimidine dimers, aromatic DNA adducts, 
and oxidative base and sugar products (reviewed in (Kastan and Bartek 2004; 
Jackson and Bartek 2009)). Proper DNA damage repair is necessary for genome 
stability, prevention of transformation, and tumor suppression. In response to 
DNA damage, cells mount finely coordinated responses and activate DNA dam-
age repair pathways, cell cycle arrest, regulation of cellular gene expression and 
cellular DNA replication.  
DNA breaks that have been induced in any way give rise to DDR signal cas-
cades. The activation of DDR can result in cell cycle arrest; however, when 
DNA damage is massive, the cell triggers apoptosis. DDR is a network of pro-
teins that regulate the preciseness of replication via detecting, signaling and 
repairing DNA lesions (Jackson and Bartek 2009). Ataxia-telangiectasia mu-
tated kinase (ATM) and ATM- and Rad3-related kinase (ATR) are the main 
kinases that regulate DNA damage detection and repair via inhibiting cell cycle 
progression after damage (Matsuoka et al. 2007; Bensimon et al. 2010). 
Different viruses use host cell DDR pathways to up- or down-regulate their 
DNA replication (EBV, SV40, and polyomavirus) (Zhao et al. 2008; Kudoh et 
al. 2009; Tsang et al. 2014). Similar to recruitment by these viruses, DDR 
components are also recruited to HPV DNA replication foci (Fradet-Turcotte et 
al. 2011; Sakakibara et al. 2011; Gillespie et al. 2012; Reinson et al. 2013). 
These viral replication compartments are very similar to cellular DNA damage 
nuclear foci. HPV can mimic DNA damage during viral genome replication and 
induce DDR pathways, which in turn enables the replication of viral DNA 
(Hong and Laimins 2013b; Wallace and Galloway 2014; Wallace and Galloway 
2015). However, the exact mechanism by which the virus takes advantage of 
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these pathways remains unknown. It has been suggested that HPV E1 protein 
can induce DSB, activating the DDR pathway, which in turn contributes to 
DNA replication machinery ((Moody and Laimins 2009; Sakakibara et al. 2011; 
Reinson et al. 2013), reviewed in (McBride 2017))  
Double-stranded DNA breaks are the most cytotoxic and difficult lesions to 
repair. Two main mechanisms are used to fix DSBs in eukaryotes – HR repair 
and non-homologous end joining (NHEJ). It has been shown that HPV recruits 
proteins involved in HR repair (NsbI, Rad51, BRCA1, pRPA S33) to the viral 
replication centers; however, proteins involved in NHEJ are not recruited 
(Gillespie et al. 2012; Anacker et al. 2014). 
 
 
Techniques to study HPV DNA replication 
To analyze the RIs that result from HPV DNA replication, we use 2D and 3D 
AGE and visualize the results using the Southern blot method (Henno et al. 
2017).  
 
Agarose gel electrophoresis 
After HPV genomes have replicated in the transient, stable, or vegetative 
replication phases, both the viral DNA products and RIs can be analyzed via 
AGE. DNA electrophoresis in agarose gel (AG) is an essential molecular biol-
ogy technique used to separate DNA molecules of different sizes and shapes. 
DNA molecules move in the electric field from cathode to anode due to their 
negative charge, which is provided by the phosphate group in their sugar-phos-
phate backbone. The rate of movement is dependent on the agarose gel matrix 
and the percentage of AG; a tighter matrix results in slower DNA movement. 
The voltage used in AGE is expressed in volts per centimeter (V/cm) (dis-
tance between the electrodes in the gel tank in cm); however, this voltage is not 
uniform because the rate of DNA movement is also dependent on the running 
buffer’s content, volume and temperature. 
To identify the replication mode of HPV genomes, we have conducted 
experiments mainly via 2D N/N and N/A and 3D N/N/A AGE. The text below 
provides an introductory overview of the conditions of these experiments and 
the resulting RIs patterns. 
Two-dimensional AGE of DNA is used to detect and analyze DNA interme-
diates that arise through DNA replication and repair. Neutral/neutral (N/N) and 
neutral/alkaline (N/A) 2D AGE are two methods used to detect and analyze 
DNA intermediates of DNA replication. N/N 2D AGE maintains the double-
stranded structures of DNA RIs throughout the experiment, whereas N/A re-
solves the dsDNA into its ssDNA components after the first dimension by ap-
plying denaturing conditions. By applying neutral/neutral/alkaline (N/N/A) 3D 







Figure 5. Schematic representation of the distribution of theta RIs in 2D N/N AGE. 
First, HPV DNA is digested at two sites; then, it is run on AGE to separate molecules 
with different sizes. Following this step, a gel slice containing separated HPV DNA is 
placed perpendicular to the first dimension, and the second dimension of 2D N/N AGE 
is conducted. The conditions of the second dimension enable the HPV RIs to be sepa-
rated based on structural complexity. Figure adapted from (Pohjoismäki 2008). 
ecules. In the first dimension, the DNA molecules are separated mostly by mo-
lecular weight (the complexity of the RI has little to no effect on its electropho-
retic mobility). In the second dimension, the DNA molecules are separated 
mainly by shape (structural complexity). These specific separations are 
achieved by using a low agarose percentage and applying a low voltage for 
DNA separation in the first dimension; using a high agarose percentage, adding 
EtBr, and applying high voltage for DNA separation in the second dimension. 
EtBr intercalates DNA molecules and makes them more rigid, thereby slowing 
down the migration process in the gel in the electric field (Bell and Byers 1983; 
Brewer and Fangman 1988; Friedman and Brewer 1995).  
N/N AGE and can then separate single strands in the third alkaline dimension. 
This method can be used to locate the parental and nascent strands. 
To better understand the interpretation of HPV DNA replication signals, the 
following section provides examples of common RIs and their patterns in 2D 
N/N, N/A and 3D N/N/A AGE. 
 
 
Neutral/Neutral 2D AGE conditions and patterns of  
replication intermediates 
N/N 2D AGE enables determination of the replication initiation region and the 
direction of replication fork (RF) migration and differences in its speed, and it 







A typical result from a 2D AGE experiment is schematically represented in Fig. 
5. HPV DNA extracted from cells is digested and separated by size in the first 
dimension and by shape in the second dimension. As a result, arcs of RIs are 
visualized via the Southern blot method. The specific conditions used to con-
duct 2D N/N AGE are described in (Henno et al. 2017). The resulting RI pat-
terns are discussed in (Henno et al. 2017) and in the next paragraphs. 
If replicating molecules with bubble structures in the center of the fragment 
are run via 2D N/N AGE, they form a bending arc that represents RIs with dif-
ferent extents of replication (Fig. 6A, labelled RI, the positions of the RIs that 
contain bubble structures are indicated above each RI arc). The smallest RIs 
have a minor bubble and are therefore located near non-replicating linear mole-
cules referred to as 1n (Fig. 6A, labelled 1n). As replication proceeds, the RI 
structures become more complexed, the bubble increases, and the movement in 
the second dimension becomes slower until the molecule almost reaches the 
size of fully replicated, but not yet separated, molecules. These molecules are 














Figure 6. Schematic representation of the distribution of theta RIs in 2D N/N AGE. 
A) Distribution pattern of RIs containing bubble structures. B) Distribution pattern of 
RIs having converging fork structures. C) Distribution pattern of RIs containing simple 
Y structures. Figure adapted from (Henno et al. 2017). 
 
 
Replicating molecules with converging fork structures form a straight arc that 
represents RIs that have different extents of replication (Fig. 6B, labelled RI, 
positions of RIs containing different dY structures are indicated above each RI 
arc). The smallest molecules are near 1n. As replication proceeds, the RI struc-
tures become more complexed, the forks at both ends of the molecule near each 
other, and movement in the second dimension slows down until the molecule 
almost reaches the size of a 2n fragment (Fig. 6B, dY structures closest to 2n). 
Replicating molecules with simple Y structures form a bending arc from 1n 
to 2n (Fig. 6C, the labelled RI and the positions of RIs that contain different Y 
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structures are indicated above each RI arc). The smallest molecules with one 
minor fork structure are near the 1n point. As the replication proceeds, the fork 
becomes larger, the RI structures become more complexed, and the movement in 
the second dimension is slower. When all three arms of the molecule are almost 
equal length, the structural complexity is at its highest; however, when the 
replicating molecules approach the size of 2n, the complexity of the RI decreases 
and the arc starts to bend downwards (Fig. 6C, simple Y structures closest to 2n). 
 
 
Neutral/Alkaline 2D AGE conditions and  
patterns of replication intermediates 
Huberman and co-workers developed a different 2D technique that uses an alka-
line second dimension (Huberman et al. 1987). The DNA molecules separated 
via a neutral first dimension are then soaked in alkaline to separate dsDNA 
strands, and the second dimension is carried out under alkaline conditions. 
These conditions resolve the dsDNA into its component single strands and 
separate nascent and parental strands while running the second dimension. 
Therefore, 2D N/A AGE separates DNA molecules by molecular weight in the 
first dimension and by strand composition in the second dimension. Because 
nascent strands are typically shorter than parental strands, they run faster in the 
second dimension, and thus, we can identify their structure based on their size. 
However, the nature of the nascent strand arcs also depends on the shape of 
nascent strands as molecular structure determines the electrophoretic mobility. 
2D N/A AGE enables detection of not only the sites of termination and origin but 
also DNA structures that are not apparent under native conditions, such as single-
strand nicks, partial duplexes, and hairpins (Schwacha and Kleckner 1994; Wahls 
et al. 2005; Lao et al. 2008; Zakharyevich et al. 2010). This technique can also 
determine the direction of RFs and their pause sites (Huberman 1997).  
The detection of RFs and the regions of termination and origin can be 
achieved by using specific hybridization probes spread throughout the DNA 
under investigation because these probes enable measurement of the length of 
nascent strands. One rule of thumb is that the hybridization probe that detects 
the shortest nascent strands is closest to the origin. Therefore, the probe de-
tecting only a small subset of nascent strands almost the size of parental strand 
is located farthest from origin (termination region). 
If replicating molecules that contain bubble structures are run via 2D N/A 
AGE, their nascent strands form a straight arc that represents ssDNA molecules 
with different sizes (Fig. 7A, labelled N). Nascent strands that originate from 
bubble RIs vary in size depending on the extent of replication, and they range in 
size from very small strands (located farthest from parental strand arc) released 
from the smallest RIs to nearly full-size nascent strands (located close to paren-
tal strand arc) released from the largest RIs. This arc reaches the size of the 





Figure 7. Schematic representation of the distribution of theta RIs in 2D N/A AGE. 
A) Distribution pattern of nascent strands released from RIs containing bubble struc-
tures. B) Distribution pattern of nascent strands released from RIs containing dYs. C) 
Distribution pattern of nascent strands released from RIs containing simple Ys. The full-
length DNA under investigation is used for hybridization to achieve these patterns. 
Figure adapted from (Henno et al. 2017). 
 
 
When replicating molecules with converging fork structures are run via 2D N/A 
AGE, their nascent strands form a bending arc that represents ssDNA molecules 
of different sizes (Fig. 7B, labelled N). Because the structure of dY molecules 
consist of two RFs, none of the nascent strands can be the same size as the pa-
rental strands. Therefore, when RFs of equal size converge, the resulting largest 
nascent strands are half the size of full-length parental strands and cannot reach 
the arc of the parental strands (Fig. 7B, compare the position of P and N arcs). 
Smallest nascent strands locate farthest from the parental strands and largest 
nascent strands locate closest to the parental strands (Fig. 7B, see small struc-
tures near the N arc). 
Nascent strands released from replicating molecules with simple Y structures 
form a bending arc that represents ssDNA molecules of different sizes (Fig. 7C, 
labelled N). Smallest nascent strands locate farthest from the parental strands 
and largest nascent strands locate close to the parental strands (Fig. 7B, see 
small structures near the N arc). 
Both 2D N/A and 2D N/N have their advantages and disadvantages. For ex-
ample, less DNA is required to obtain a sufficient signal via 2D N/N because 
the parental strands are not separated from nascent strands, thereby increasing 
the local concentration. Additionally, a single restriction analysis can be ob-
tained from a single hybridization via 2D N/N, whereas analysis of a single 
fragment using N/A electrophoresis requires at least two hybridizations (one 
probe for both ends of the fragment). However, 2D N/A provides information 
about the direction of each RF, whereas 2D N/N only provides that kind of in-
formation when utilizing in-gel restriction before applying the second dimen-
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sion. In addition, the regions of origin and termination can be more accurately 
defined via 2D N/A because the sizes of nascent strands can be more accurately 
compared to parental strands. A good strategy to analyze unknown RIs is to use 
both 2D N/N and 2D N/A because they compensate for one another by 
discriminating between replication intermediates with identical masses, but 
subtle structural differences. Furthermore, to confirm the results obtained via 
2D N/N and 2D N/A assays, we also conduct 3D N/N/A AGE. 
 
 
Neutral/Neutral/Alkaline 3D AGE conditions and  
patterns of replication intermediates 
The technique of applying 3D N/N/A AGE was introduced by (Liang and Gerbi 
1994). This method enables the separation of DNA fragments by size in the first 
dimension and by shape in the second dimension and finally resolves the 
intermediates into parental and nascent strands in the alkaline third dimension. 
The first two dimensions are carried out in the same manner as 2D N/N AGE. 
The gel is then soaked in alkaline to separate dsDNA strands, and the third 
dimension is carried out in an alkaline electrophoresis buffer in the same direc-
tion as the first dimension or the second dimension. One possibility is to soak 
the entire AG obtained from the second dimension in alkali and then run the gel 
under alkaline conditions (Lucas and Hyrien 2000; Orav et al. 2015; Henno et 
al. 2017); another possibility is to cut out narrow gel slices perpendicular to the 
first dimension and then conduct the assay in the same manner as the second 
dimension of 2D N/A AGE (Liang and Gerbi 1994; Kalejta and Hamlin 1996). 
RIs separated in the second dimension form arcs of common structures, such 
as forks and bubbles that are resolved into parental and nascent strands in alka-
line conditions prior to the third dimension. The third dimension of 3D N/N/A 
separates the nascent and parental strands. Because parental strands have re-
tained their size, they migrate the same distance and therefore maintain approxi-
mately the same shape of the original dsDNA arcs as after the second neutral 
dimension. However, nascent strands form unique arcs due to their faster mi-
gration because of their smaller size (Orav et al. 2015; Henno et al. 2017). 
The technique of N/N/A 3D gel electrophoresis enables determination of the 
size of forks and bubble intermediates and detects ssDNA in joint DNA mole-
cules (Kalejta and Hamlin 1996; Lucas and Hyrien 2000). Because the migra-
tion of RIs in the first dimension is also influenced by molecular shape, RIs 
might not run at the same rate as linear molecules of the same mass even under 
conditions of low AG percentage and low voltage (Liang and Gerbi 1994). 3D 
N/N/A assays are able to solve this problem by separating forks and bubbles 
into single strands and resolving them solely by size in the third dimension. 
Additionally, in (Kalejta and Hamlin 1996), the researchers were able to detect 






When replicating molecules with bubble structures are run via 2D N/N AGE 
and their nascent strands are separated from parental strands during an alkaline 
third dimension, these nascent strands form a bending arc that represents 
ssDNA molecules of different sizes (Fig. 8A, labelled N). Nascent strands that 
originate from bubble RIs vary in size depending on the extent of replication, 
and they range in size from very small strands (located farthest from parental 
strand arc) released from the smallest RIs to nearly the size of parental strands 
(located close to parental strand arc) released from the largest RIs (Fig. 8A, see 
the small structures near the bubble arc). 
 
Figure 8. Schematic representation of the distribution of theta RIs in 3D N/N/A 
AGE. A) Distribution pattern of nascent strands released from RIs containing bubble 
structures. B) Distribution pattern of nascent strands released from RIs containing dYs. 
C) Distribution pattern of nascent strands released from RIs containing simple Ys. The 
full-length DNA under investigation is used for hybridization to achieve these patterns. 
Figure adapted from (Henno et al. 2017). 
 
 
Nascent strands released during an alkaline third dimension from the arc of RIs 
with converging fork structures form a bending arc that represents ssDNA 
molecules of different sizes (Fig. 8B, labelled N). Because the structure of dY 
molecules consists of two RFs, no nascent strands can be the same size as their 
parental strands. Therefore, when RFs of equal sizes converge, the resulting 
largest nascent strands are half the size of the full-length parental strands and 
cannot reach the arc of the parental strands (Fig. 8B, compare the position of P 
and N arcs). Smallest nascent strands locate farthest from the parental strands 
and largest nascent strands locate closest to the parental strands (Fig. 8B, see 
small structures near the N arc). 
Nascent strands released from the arc of replicating molecules with simple Y 
structures obtained from 2D N/N AGE form a bending arc that represents 
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ssDNA molecules of different sizes in the alkaline third dimension (Fig. 8C, 
labelled N). Smallest nascent strands locate farthest from the parental strands 
and largest nascent strands locate close to the parental strands (Fig. 8B, see 
small structures near the N arc).  
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OBJECTIVES OF THIS STUDY 
HPV DNA replication mechanisms have been extensively studied; however, the 
results are often inconsistent. Because our group has previously developed a 
model system to study HPV genome replication (Geimanen et al. 2011), we 
conducted replication assays using different HPV types and inspected their RIs 
and replication mechanisms mainly via 2D AGE.  
The general aim of this study was to analyze the replication mechanisms of 
HPVs by examining the RIs produced within U2OS cells using 1D, 2D, and 3D 
AGE methods. Specifically, this study focused on the following: 
 
 Examining the oligomeric state of various HPVs within U2OS cells and in 
clinical samples obtained from patient tissues. 
 Characterizing the necessary viral factors for HPV oligomer generation. 
 Providing an overview of the important aspects to consider while inter-
preting the results obtained via N/N, N/A 2D and N/N/A 3D AGE. 
 Characterizing HPV DNA replication intermediates using 2D and 3D 
methods in U2OS cells during the first amplification phase.  
 Identifying possible replication mechanisms that could govern HPV18 ge-
nome replication in U2OS cells during the first amplification phase using the 
results obtained while characterizing the RIs.  
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MATERIALS AND METHODS 
All experiments were conducted during the first amplification phase of HPV 
genome replication within a U2OS cell line based model system (Geimanen et 
al. 2011). The U2OS cell line (originally 2T) was derived from a 15-year-old 
girl’s moderately differentiated osteosarcoma (Ponten and Saksela 1967). U2OS 
cells are HPV negative; however, they express pRB and p53 proteins and have a 
morphology similar to keratinocytes. These cells support HPV DNA replication 
very efficiently and can mimic the initial amplification of HPVs, the stable 
maintenance phase, and the second amplification phase of the HPV replication 
cycle. These cells, however, cannot support the productive phase of the HPV 
life cycle. 
To improve the efficiency of conducting experiments with HPV genomes, 
we utilized the minicircle manufacturing system developed in (Kay et al. 2010). 
The minicircle DNA vector consists of a circular expression cassette devoid of 
the bacterial plasmid DNA backbone. As a result, minicircles mimic the natural 
physical state of HPV genomes after they enter the host cells. Exclusion of the 
bacterial vector and circularizing of the HPV plasmids prior to transfection 
reduces the initiation time, and thus, minicircle HPV DNA starts to replicate 
much faster in the U2OS cell line compared to HPV DNA that is provided as 
linear or loose circles (Ref. I). The precise protocol of the production of 
minicircles is provided in Ref. III. 
In addition to using an efficient model system and HPV DNA production, 
we also utilized an HPV18 E8 mutant. This plasmid begins to replicate much 
more efficiently compared to HPV18wt in the U2OS cell line (Kurg et al. 2010; 
Reinson et al. 2013), which results in the same pattern with stronger signals and 
thus better visualization of HPV DNA RIs in 2D and 3D assays. 
Most of the experiments are conducted with low molecular weight (LMW) 
DNA extracted from U2OS cells approximately 3–5 days after transfection with 
HPV genomes. We modified the common Hirt extraction protocol to preserve 
the fragile nature of DNA replication structures. The precise protocol of the 
LMW DNA extraction from U2OS cells is provided in Ref. III. 
We analyzed HPV RI via 1D, 2D, and 3D AGE. Because multidimensional 
AGE experiments are technically challenging to carry out, Ref. III provides a 




RESULTS AND DISCUSSION 
The research group of human papillomavirus DNA replication within the Insti-
tute of Technology at Tartu University has developed an effective cellular 
model system to study the various genome replication methods carried out by 
different HPVs. The system is based on transfecting HPV genomes into human 
osteosarcoma cell line U2OS, where they are able to replicate (Geimanen et al. 
2011). To mimic the circular covalently closed forms of HPV genomes in real 
life, we adopted minicircle technology (Kay et al. 2010), which makes using 
our model system even easier. 
We use this novel model system to study the generation of oligomers of the 
viral genomes during the initial phase of replication. This short establishment 
phase of HPV genomes (initial amplification) can be mimicked by transfecting 
the U2OS cells with HPV genomes and extracting the replicated LMW HPV 
DNA several days later. We have identified that after transfection of the HPV 
molecules into U2OS cells, the viral DNA replicates and produces concatemeric 
genomic oligomers. The oligomer generation of viral genomes in host cells is a 
novel subject of research and not much is known about this phenomenon 
(Geimanen et al. 2011; Orav et al. 2013). It is not known how extensive the 
presence of oligomers is in nature, even though they were demonstrated in biop-
sies from cervical carcinomas over 30 years ago (Durst et al. 1985). 
Using 2D N/N and N/A AGE, we conducted several assays to describe RIs 
of the HPV18 genomes during a transient DNA replication period.  
 
 
Replication and oligomer generation of  
HPV genomes in U2OS cells (I) 
After transfecting HPV genomes into U2OS cells and extracting LMW DNA at 
different time points, we observed that viral DNA replication yields oligomeric 
molecules that tended to become more prevalent over time (Ref. I, Fig. 1C). We 
showed that these oligomers are concatemeric circular head-to-tail tandems 
(Ref. I, Fig. 2B). The head-to-tail orientation was confirmed by partial diges-
tion; digestion with a little concentration of enzyme yielded large linearized 
oligomers that cannot be obtained from catenated interlocking rings, which can 
also form oligomers (because partial digestion would only yield linear mono-
mers and not higher oligomers) (Ref. I, Fig. 2B, see lanes 2–6 and 10–12). As 
the concentration of enzyme increased, these large molecules disappeared due 
to complete digestion. 
 
 
Topology of input DNA  
We have also shown that oligomers are generated independently of the 
topological form of the input DNA. This means that whether we transfect cells 
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with linear, open circle (oc) or covalently closed circular (ccc) HPV genomes, 
the outcome is the same: oligomers appear and become more prevalent over 
time (Ref. I, Fig. 1A and 1B). Only the onset of replication is dependent on the 
physical state (linear, oc or ccc) of input DNA, as transfection with linearized or 
ccc HPV18 E8 mutant genomes provides signals with different intensities (Ref. 
I, Fig. 1A, compare lanes 1–7 to 8–15 and 16–23). 
To exclude the possibility that oligomer generation only occurs in U2OS cell 
lines, we have shown that this phenomenon also occurs in other cell lines, such 
as SiHa (Ref. I, Fig. 7A, lanes 1–3; Fig. 7C, lanes 1–9), HeLa (Ref. I, Fig. 7B, 
lanes 5–7; Fig. 7C, lanes 10–18), and C-33 (Ref. I, Fig. 7D, lanes 7–9; Fig. 7E, 
lanes 1–3 and 7–9), in addition to previous indications in other cell lines, such as 
primary human keratinocytes (Bodily et al. 2011), W12 (Alazawi et al. 2002), 
and CIN612 (Hong and Laimins 2013a). We also confirmed the presence of 
oligomers in HPV-infected patient tissue samples (Ref. I, Fig. 8A, lanes 17–19, 
Fig. 8B, lanes 13–15) in addition to previous indications of oligomers in clinical 
samples (Durst et al. 1985; Cullen et al. 1991; Kristiansen et al. 1994; Adachi et 
al. 1996). Therefore, we can conclude that the oligomeric state is part of the 
HPV life cycle. 
 
 
Role of viral proteins in the process of formation of oligomers 
We examined the role of HPV proteins during oligomer creation by generating 
HPV18 mutant genomes that lack one or more early open reading frames. We 
excluded the creation of L1 and L2 mutants from this experiment because as 
Ref. I Fig. 5B (lanes 1–4) indicates, an HPV18 sub-genomic construct without 
L1 and L2 ORFs is able to produce oligomers. Therefore, we only induced 
mutations that eliminate the expression of E1, E2, E6, E7, E8, E4, E1^E4, and 
E5 (Ref. I, Fig. 3).  
E1 and E2 mutants were not able to replicate, as predicted, and thus were not 
able to generate oligomers (Ref. I, Fig. 3, lanes 10–12 and 16–18). 
E6 and E7 mutants retained the capability of generating oligomers (Ref. I, 
Fig. 3, lanes 4–9), whereas an E7 mutant even produces a higher signal of 
replication and more intense oligomer formation compared with HPV18wt (Ref. 
I, Fig. 3, compare lanes 1–3 to lanes 7–9). The E8 mutant, as previously de-
scribed, replicated much more efficiently than wt, leading to more efficient 
oligomer generation (Ref. I, Fig. 3, lanes 13–15). Mutations to E4 (Ref. I, Fig. 3, 
lanes 19–21), E1^E4 (Ref. I, Fig. 3, lanes 22–24), and E5 (Ref. I, Fig. 3, lanes 
25–27) did not alter the pattern of oligomerization during viral DNA replication. 
Thus, we can conclude that although the replication efficiency and consequently 
the oligomer generation efficiency fluctuated, the pattern of oligomeric mole-
cules remained unchanged. 
In conclusion, the results indicate that oligomers are generated in all (E6, E7, 
E8, E4, E1^E4, and E5) mutants, except for E1 and E2 mutants, which are not 






no viral proteins, except for E1 and E2, are necessary for oligomer generation 
when replicating HPV18 genomes. Additionally, we can conclude that oligomer 
formation is a replication dependent process. 
 
 
HPV18 URR region is capable of E1 and  
E2 dependent replication and oligomerization  
To also investigate the potential overlap of replication and the formation of 
oligomers, we conducted an assay with an HPV18 URR construct that was gen-
erated from a BamHI-BamHI fragment obtained from the full-length HPV18 
genome (Fig. 9). The URR construct contains the origin of HPV replication; 
however, replication can be achieved by co-transfecting it with the full HPV18 
genome (schematically shown in Fig. 10A) or with E1 and E2 expression plas-
mids (schematically shown in Fig. 10B) as a source of viral replication proteins.  
 
Figure 9. Schematic representation of HPV18 genome. Digesting the HPV18 ge-
nome with BamHI enzyme yields an approximately 1.1 kbp long URR construct. 
 
 
To analyze the ability to both replicate and produce oligomers, U2OS cells were 
transfected with HPV18 URR minicircle DNA together with E1 and E2 expres-
sion vectors (Ref. I, Fig. 4B, lanes 5–10) or with a full-length HPV18 genome 
(Ref. I, Fig. 4B, lanes 1–4). However, when we co-transfected HPV18wt and 
URR genomes to characterize their replication patterns, we utilized a restriction 
enzyme that linearizes full-length HPV18 but leaves HPV18 URR undigested 
(schematically shown in Fig. 11A). As a result of these co-transfections, the 
URR region began to replicate and oligomers formed as a series of discrete 
bands. We suggest that the difference between the signal strengths of replication 
is due to differences in the amount of E1 and E2 proteins expressed. The levels 
of E1 and E2 expressed in these systems is much higher than those produced by 
the wt genome (Ref. I, Fig. 4B, compare lanes 1–2 to lanes 5–6). We observe 
that the pattern of oligomeric molecules that originate from URR regions is the 
same when using either co-transfection with E1 and E2 expression vectors (Ref. 






Figure 10. Schematic representation of the two possibilities for HPV18 URR repli-
cation. A) Co-transfection of HPV18 URR and HPV18wt results in replication and 
oligomerization of both constructs. B) Co-transfection of HPV18 URR and E1 and E2 
expression plasmids results in replication and oligomerization of the HPV URR construct. 
 
 
Taken together, we can conclude that the efficiency of oligomerization depends 
on the efficiency of replication (Ref. I, Fig. 4B, lanes 1–6) and that the pattern 
of oligomer formation remains unchanged, independently of the source or ex-
pression levels of viral replication proteins E1 and E2. 
To further confirm the existence of oligomers, we conducted 2D gel electro-
phoresis (Ref. I, Fig. 4C and 4E). It is clear that arcs on linear, covalently 
closed circular (marked as 1xccc, 2xccc, etc.) and open circular DNA forms 
(marked as 1xoc, 2xoc, etc.) were present, both in the case of transfecting 
HPV18 URR with E1 and E2 expression vectors (Ref. I, Fig. 4C) or with 
HPV18 full genome (Ref. I, Fig. 4E). These arcs represent monomeric, dimeric 
and higher oligomeric molecules of HPV18 URR. In conclusion, we have 
demonstrated that the phenomenon of oligomerization can occur in a region 
even as small as the HPV origin.  
In addition, the work presented in my Master’s thesis (Henno 2013) showed 
that replication and oligomer generation can occur in much smaller regions of 
HPV18 URR when co-transfected together with E1 and E2 expression vectors. 
However, co-transfection of regions, excluding the origin of replication, with 
full-length HPV18 or E1 and E2 expression vectors did not yield replication or 
oligomerization (data not shown). In summary, oligomer generation is strictly 
dependent on the presence of the origin of replication, and because no open 
reading frame expression occurs with the URR construct, we can distinguish 






Mechanism(s) behind oligomer generation  
To clarify the mechanism behind the generation of oligomers, we conducted 
separate assays with the full-length HPV18 genome, its sub-genomic fragments, 
and HPV11 E1 and E2 mutant genomes. 
Figure 11. Schematic representation of the generation of hetero-oligomers. Scissors 
indicate the restriction sites in HPV DNA in the current experiment. A) Co-transfection 
of HPV18wt and HPV18E yields hetero-oligomers that can be seen using an enzyme 
that has a recognition site only in HPV18wt. B) Co-transfection of HPV18wt and 
HPV18 URR yields hetero-oligomers that can be seen using an enzyme that has a 
recognition site only in HPV18wt. C) Co-transfection of a HPV11 E1 mutant and a 
HPV11 E2 mutant yields hetero-oligomers that give specific digestion patterns in the 
AGE, where one restriction site has been mutated in both of the mutants. 
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First, we used the full-length HPV18 genome and its sub-genomic construct 
HPV18E, which lacks the late ORFs of HPV18 but has the ability to replicate 
and oligomerize. When HPV18 and HPV18E were transfected into the U2OS 
cell line and the resulting DNA was further analyzed, we observed a pattern of 
RIs and oligomers from both genomes (Ref. I, Fig. 5B, lanes 1–4, 13–16). In 
follow-up experiments, we separated the RIs of HPV18 from RIs of HPV18E 
using a restriction enzyme that linearizes full-length HPV18 but leaves 
HPV18E undigested (schematically shown in Fig. 11A). As a result, we ob-
tained bands of linearized HPV18 (Ref. I, Fig. 5B, lanes 5–8, arrowhead indi-
cating to linear fragment with a size of 8 kbp referred to as 1 lin) and mono-
mers, dimers and higher oligomers of HPV18E. However, we also obtained 
linear fragments with the lengths of one full-length and one HPV18E genome 
(schematically shown in Fig. 11A) (Ref. I, Fig. 5B, lanes 5–8, arrow pointing to 
13.4 kbp fragment). This result means that they have somehow formed joint 
molecules: hetero-oligomers (Ref. I, Fig. 5B, compare lanes 1–4 and 9–12 to 
lanes 5–8). In addition, we observed an 18.8 kbp joint molecule consisting of 
two HPV18E genomes and one HPV18 genome and a 24.2 kbp joint molecule 
consisting of three HPV18E genomes and one HPV18 genome (Ref. I, Fig. 5B, 
arrows point to hetero-oligomers). 
Next, to identify possible joint molecules of HPV18 URR and full-length 
HPV18, URR was transfected into U2OS cells together with HPV18. The 
extracted HPV DNA was digested with an enzyme that linearizes full-length 
HPV18 but leaves HPV18 URR undigested (schematically shown in Fig. 11B). 
As a result, we obtained bands of linearized HPV18 (Ref. I, Fig. 4B, lanes 1–4, 
arrowhead indicating an 8 kb linear fragment) and oligomers of HPV18 URR 
(Ref. I, Fig. 4B, lanes 1–4, area marked as oligomers). To better visualize the 
HPV18 URR oligomers, we conducted 2D N/N AGE (Ref. I, Fig. 4E, long 
expo) where we could observe joint molecules in a short exposure of a film 
(Ref. I, Fig. 4E, short expo, arrows indicate hetero-oligomers). These oligomers 
represent molecules that have one HPV18 genome and one URR genome (9 
kbp) (schematically shown in Fig. 11B), one HPV18 genome and two URR 
genomes (10 kbp), and one HPV18 genome and three URR genomes (11 kbp), 
among others. These experiments, once again, demonstrate the presence of 
hetero-oligomers. A schematic representation of one possible way to create 







Figure 12. Schematic representation of one possible way of generating hetero-
oligomers between HPV18 URR and full-length HPV18. Scissors indicate the re-
striction sites in HPV DNA in the current experiment and yellow indicates newly syn-
thesized DNA. Co-transfection of HPV18wt and HPV18 URR yields hetero-oligomers 
that can be seen using an enzyme that has a recognition site only in HPV18wt.  
Finally, we performed an additional experiment where we co-transfected two 
HPV11 E1 and E2 mutants not capable of replicating alone. Full-length 
HPV11wt has PaeI and SdaI restriction sites, the E1 mutant we used lacked 
PaeI and the E2 mutant lacked SdaI (schematically shown in Fig. 11C) (Ref. I, 
Fig. 6, lower panel showing restriction sites of monomers). Co-transfection of 
HPV11 E1 and E2 mutant genomes resulted in replication; therefore, they must 
have complemented each other’s mutations (Ref. I, Fig. 6, upper panel, lanes 
13–16, band of 8 kbp). In addition, oligomers of HPV11 E1 and E2 mutant ge-
nomes were generated (Ref. I, Fig. 6, upper panel, lanes 5–8). Oligomers con-
sisting of only HPV11 E1 mutant genomes would have only SdaI restriction 
site, and oligomers consisting of only HPV11 E2 mutant genomes would have 
only PaeI restriction site. As a result, digestion with SdaI and PaeI yielded 8 
kbp linearized monomers. However, when digesting the HPV DNA obtained 
from co-transfection of HPV11 mutants with SdaI and PaeI restriction enzymes, 
we also obtained linearized fragments with sizes of 6 kbp and 10 kbp (Ref. I, 
Fig. 6, upper panel, lanes 13–16, arrowheads indicating 6 kbp and 10 kbp). 
These fragments can be obtained from linearizing an oligomer consisting of 
both the HPV11 E1 and E2 mutant genomes, a hetero-oligomer that has one 
PaeI and one SdaI digestion site (schematically shown in Fig. 11C).  
Several mechanisms are associated with replication and oligomer formation. 
Oligomers generated through RCR use a single molecule as a template to create 
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only homo-oligomers. However, creation of hetero-oligomers is possible only 
through HR-dependent replication, which occurs between two separate mole-
cules that can be partially homologous or fully homologous with one acting as 
the donor and one as a template. As mentioned in the literature review above, 
papillomaviruses are very dependent on host factors; therefore, it is likely that 
HPVs utilize factors involved in host DDR and/or HR pathways to replicate and 
generate oligomers (reviewed in (Sakakibara et al. 2013)). In the process of HR, 
two different molecules that have a homologous sequence form a linkage fol-
lowed by strand exchange, which results in a new combination of DNA strands. 
The end products of HR may contain crossover structures referred to as Hol-
liday junctions (HJ) (Li and Heyer 2008), which might be resolved in a way that 
leads to the generation of oligomeric molecules. However, RDR can synthesize 
large amounts of concatemeric DNA that must later be resolved into unit-sized 
viral genomes (reviewed in (Lo Piano et al. 2011)). This process makes it 
probable that cellular repair factors involved in RDR can resolve HPV oligo-
meric structures into monomeric, circular genomes. The exact mechanisms of 
oligomer generation and how they are resolved must still be elucidated. 
In conclusion, these experiments indicate that at least HPV genomic hetero-
oligomers can arise through the homologous recombination step of replicating 
viral genomes. We have not yet identified which repair machinery related to 
viral DNA synthesis is involved; however, some have been predicted based on 
an analogy to some BIR-related mechanisms with unidirectionally moving RF 
(Malkova and Ira 2013). We suggest that HR-directed and repair-related 
replication mechanisms could also be responsible for the formation of standard 
HPV genomic homo-oligomers (oligomers consisting of identical genomes); 
however, the RCR mechanism cannot be excluded.  
The reason why the oligomeric state has been taken into use by the virus can 
be explained by the necessity to keep a low profile in the host organism. BPV1 
oligomers have been shown to have only one active origin (Schvartzman et al. 
1990) that can replicate an entire oligomer consisting of many monomers using 
as many host and viral replication proteins as a monomer would. Therefore, 
much more viral DNA can be replicated while eluding the host adaptive im-
mune system. This mechanism is also supported by the fact that viral genomes 
exist mainly as episomal oligomers in HPV-positive U2OS sub-clones that were 
designed by our research group (Geimanen et al. 2011). 
 
 
Analysis of replication intermediates and  
the mechanism(s) behind HPV DNA replication (II and III) 
We stated above that performing 2D gels is technically challenging and that 
interpretation of the results is even more difficult. Interpretation is based on a 
comparison of unknown RIs patterns with known, well-defined replication 
intermediates. Both Ref. II and III address the characterization of HPV18 RIs. 
Ref. II concentrates mainly on the mechanism behind replication and III in-
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cludes an overview of the experimental procedures and an understanding of RI 
patterns obtained from 2D and 3D AGE. 
 
 
Analysis of undigested HPV DNA via 2D N/N AGE 
2D N/N AGE separates undigested replicating HPV genomes into patterns (spe-
cific arcs) of open circle, covalently closed circles, and linear HPV fragments 
(Ref. II, Fig. 1A, marked as oc, ccc and lin, respectively). These different 
topological forms of DNA were separated from each other due to their different 
mobility in AGE.  
First, two days after transfection of HPV18 into U2OS cells, we observed 
only linear, oc and ccc monomeric molecules; however, at later time points, 
oligomers accumulated (Ref. II, Fig. 1A 2–9 days). To confirm the physical 
states of these RI signals, HPV genomes were digested with an enzyme that 
nicked the ccc molecules into oc structures so that we could identify their posi-
tions on 2D gels (Ref. II, Fig. 1B). 
To obtain stronger signals of these RIs, we used an HPV18 E8 mutant that 
replicates more efficiently than HPV18wt (Kurg et al. 2010; Reinson et al. 
2013). In addition to the arcs formed from different forms of HPV DNA mole-
cules, we also observed arcs of replicating molecules that showed an increase in 
molecular weight in addition to changes in topological complexity (Ref. II, Fig. 
1C, white bold arrow, black bold and narrow arrow; Ref. III, Fig. 14B.10.6B, 
black bold arrow). The scheme depicted in Ref. II, Fig. 1D indicates the loca-
tions of the arc of RCR and bidirectional theta replication (Belanger et al. 1996; 
Martin-Parras et al. 1998). In our analysis, we can clearly see the arc of bidirec-
tional theta RIs originating from 1 ccc molecules (Ref. II, Fig. 1C, black bold 
arrow; Ref. III, Fig. 14B.10.6B, black bold arrow). The arc emanating from 2 
ccc/1 oc has similar characteristics, but its origin is unclear (Ref. II, Fig. 1C, 
white bold arrow). Additionally, the diffuse arc between 1 ccc and 2 ccc has an 
unidentified origin (Ref. II, Fig. 1C, black narrow arrow). In addition, we ob-
serve that the arc of RCR intermediates is not present (Ref. II, compare Fig. 1C 
to Fig. 1D, marked as σRIs). To better visualize these RIs, we used restriction 
enzyme analysis to study linearized full-length HPV and linearized sub-
genomic fragments of the HPV genome via 2D AGE assays. 
 
 
Analysis of single-digested HPV DNA via 2D N/N AGE 
It has previously been stated that HPVs replicate using a bidirectional theta 
replication mechanism (Yang and Botchan 1990; Auborn et al. 1994). Bidirec-
tional replication has been thoroughly described, including the resulting inter-
mediates (Friedman and Brewer 1995). Patterns of common theta RIs, such as 
an arc of simple Ys, converging forks (dY), and bubble molecules, are 
schematically presented in Fig. 6 and Ref. II, Fig. 2B. If we linearize the HPV 
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genome near the origin of replication, we get an arc of converging fork mole-
cules (Ref. II, Fig. 2B panel of dY intermediates). However, when we digest the 
HPV DNA opposite of the origin, it yields an arc of bubble intermediates (Ref. 
II, Fig. 2B, panel of replication bubble intermediates). Simple Ys originating 
from a bidirectional replication mechanism can be obtained if the HPV genome 
has been digested at two adjacent regions, whereas one digestion site is in the 
region of the origin (Ref. II, Fig. 2B panel of simple Y intermediates). 
When analyzing the replication of HPV18 digested at the site of origin, we 
can see the common theta replication intermediates – dYs (Ref. II, Fig. 2A, 
black bold arrow). However, our assay also indicates the presence of yet 
another signal two days after transfecting the HPV18wt genome into U2OS 
cells (Ref. II, Fig. 2A, white bold arrow). These molecules must represent some 
sort of RIs because they show an increase in molecular weight coupled with 
structural complexity and they seem to accumulate as time passes (Ref. II, Fig. 
2A, compare 2 days, 3 days and 5 days). We propose that these intermediates 
are generated through some other type of replication mechanism (and not the 
more commonly known bidirectional theta replication). Perhaps it is a homolo-
gous recombination directed and repair-related replication mode as seen during 
the generation of hetero-oligomers. The quite universal, but not clearly identi-
fied, RI patterns are present in every replication assay of once linearized 
HPV18 DNA. In this text, we refer to it as the novel replication mechanism. In 
addition to common theta structures and intermediates of the novel mechanism, 
we can also see the presence of large branched structures that migrate at the end 
of the signal of theta replication structures (Ref. II, Fig. 2A, black arrowhead). 
We propose that these signals represent late theta intermediates, where the 
replication forks have stalled before separation of the replicated molecule into 
the daughter genomes. This kind of accumulation of theta intermediates has also 
been noted in SV40 replication (Tapper and DePamphilis 1978; Seidman and 
Salzman 1979; Tapper and DePamphilis 1980). 
To further confirm the presence of this novel replication mechanism, we 
conducted 2D assays using the HPV18 E8 mutant through which we obtained 
stronger signals of replication and therefore, clearer images. HPV18 E8 mutant 
DNA was extracted from U2OS cells three days post transfection. The theta 
replication mechanism gives rise to the familiar arcs of dY (Ref. II, Fig. 3A, 
BglI and Bpu1102I, black bold arrow; Ref. III, Fig. 14B.10.7C, BglI, black 
bold arrow) or bubble intermediates (Ref. II, Fig. 3A, XmaJI and PsyI, black 
bold arrow; Ref. III, Fig. 14B.10.7D, PsyI, black bold arrow) when digesting 
the HPV DNA near the origin or the termination regions, respectively. The bub-
ble arc, however, shifts into an upward tilted diffuse signal when RIs occur near 
the 2n point because some molecules are transitioned into dY structures due to 
the choice of enzymes (BglI and Bpu1102I), which do not digest exactly at the 
origin of replication (Ref. III, Fig. 14B.10.7D and 14B.10.7G). The diffuseness 
of the signal could also be explained by the different speed of the replication 
forks. All images contain common arcs and structures (originating from a novel 
mechanism) that do not change when using different restriction enzymes (Ref. 
43 
II, Fig. 3A, white bold arrow; Ref. III, Fig. 14B.10.7C-D, white bold arrow), 
which were also present in an HPV18wt assay we conducted (Ref. II, Fig. 2A, 
white bold arrow). This kind of unchangeable pattern independent of the 
restriction sites indicates that the novel mechanism does not seem to have a 
certain origin for HPV18 DNA replication. 
 
 
Analysis of single-digested HPV DNA via 2D N/A AGE 
To better understand the structural complexity of novel RIs, we conducted a 2D 
N/A AGE assay (Ref. II, Fig. 4; Ref. III, Fig. 14B.10.8). This 2D AGE method 
applies a neutral gel electrophoresis separation step followed by another in the 
alkaline dimension. This divides the parental and nascent strands of molecules 
undergoing replication. As a result, the pattern of linearized RIs is entirely 
different from that obtained using N/N AGE conditions. The 2D N/A method 
helps to determine the existence of bi- and/or unidirectional forks and to detect 
nascent ssDNA originating from RIs with bubble, Y, and dY structures. Ref. II, 
Fig. 4A indicates the resulting patterns of single strands that originate from 
simple Y, bubble, and dY intermediates. A detailed explanation is provided in 
the literature overview section of this dissertation (Fig. 7). 
To better understand the HPV18 RIs pattern obtained through 2D N/A, we 
conducted 2D N/N to locate the positions of previously described and well-
identified intermediates. The conditions for running the first dimension were the 
same; thus, we can draw lines to see where intermediates migrated in first 
dimension (Ref. II, Fig. 4B and 4C, compare upper and lower panel). When 
digesting HPV18 genomes near the origin (BglI), we obtained dYs (Ref. II, Fig. 
4B, black bold arrow) as previously described, whereas digesting opposite of 
the origin (XmaJI) yielded bubble intermediates (Ref. II, Fig. 4C, black bold 
arrow). Single strands originating from dY intermediates constitute a bending 
arc that does not reach the size of parental strands (due to having two replica-
tion forks) and single strands from bubble intermediates form a straight line that 
almost reaches the position of parental strands. This result is because XmaJI 
does not digest exactly at the termination of replication, and therefore, RIs con-
tain a proportion of dY molecules in addition to bubble RIs (Ref. III, Fig. 
14B.10.8B and 14B.10.8E). Both in the case of bubble and dY intermediates, 
we can identify that the largest molecules (late theta RIs) are situated in the top 
left corner of the gel (Ref. II, Fig. 4B and 4C, black arrowheads, compare upper 
and lower panel; Ref. III, Fig. 14B.10.8D-E, marked as 2n). In addition, we can 
see the arcs of single strands that originate from novel replication mechanism 
intermediates (Ref. II, Fig. 4B and 4C, white arrowheads and white bold ar-
rows; Ref. III, Fig. 14B.10.8D-E, white and grey bold arrows). When analyzing 
the replication of HPV18 DNA using N/A AGE, we can verify that the signals 
of the novel replication mechanism do not differ when using two distinct 
restriction enzymes that digest at different regions of the HPV18 genome (Ref. 
II, compare Fig. 4B and 4C, white arrowheads and white bold arrows; Ref. III, 
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compare Fig. 14B.10.8D and Fig. 14B.10.8E, white and grey bold arrows). 
When we analyse these signals, we can see that the smallest single strands origi-
nating from RIs form a straight arc that is characteristic of nascent strands origi-
nating from bubble structures (Ref. II, Fig. 4B and 4C, white bold arrows; Ref. 
III, Fig. 14B.10.8D-E, white bold arrows). However, when replication con-
tinues, the arc of single stranded molecules starts to bend and resembles the 
pattern of ssDNAs that originate from simple Ys or severely asymmetrical dYs 
(Ref. II, Fig. 4B and 4C, white arrowheads; Ref. III, Fig. 14B.10.8D-E, grey 
bold arrows). Thus, we propose that when the novel replication mechanism is 
initiated, the intermediates resemble bubble structures because their arc of nas-
cent strands partially converges with the ssDNA arc that originates from early 
bubble RIs of theta replication. However, they cannot be identical because they 
have different patterns in 2D N/N AGE. When the novel replication mechanism 
continues, we see that the ssDNAs that originate from RIs form an arc re-
sembling ssDNA that originates from simple Y RIs because the arc starts to 
bend. This result can be explained by the digestion of novel RI bubble-resem-
bling structures into simple Y structures (as the bubble has increased in size and 
therefore is more likely to be digested). Before the newly synthesized molecule 
is fully replicated, the structure is unknown (Ref. II, Fig. 4B and 4C, white 
arrowheads; Ref. III, Fig. 14B.10.8D-E, gray bold arrows). 
 
 
Analysis of single-digested HPV DNA via 3D N/N/A AGE 
To further confirm the composition HPV RIs, we conducted 3D N/N/A AGE 
assay (Ref. II, Fig. 3B; Ref. III, Fig. 14B.10.9). 3D N/N/A method involves 
soaking 2D N/N gel in alkali and separating parental and nascent strands in a 
third dimension (Ref. III, compare 2D N/N assay in Fig. 14B.10.9E to 3D 
N/N/A assay in Fig. 14B.10.9F, parental and nascent strands are marked black 
and red dotted lines). We can see that the intermediates of novel mechanism 
contain bubble or simple Y structures, as we cannot distinguish between them 
via 3D assay (schematic representation of the location of parental and nascent 
strands of bubble and simple Y is depicted in Ref. III, in Fig. 14B.10.9B-C). 
The smallest theta intermediates have a weak signal and this observation could 
be the reason why we cannot see their nascent strands. However, late theta 
intermediates have stronger signals and we can also detect their nascent strands 
(Ref. III, Fig. 14B.10.9F, marked with a black bold arrow). The arc of nascent 
strands implies that the RIs contain converged forks in different positions in the 
HPV genome (Ref. III, compare schematic representation in Fig. 14B.10.9D to 
3D N/N/A assay in Fig. 14B.10.9F). This result supports the hypothesis that the 





Analysis of linearized HPV18 sub-genomic  
fragments via 2D N/N AGE 
To further analyze the composition of the novel RIs, we analyzed the sub-
genomic fragments formed from the HPV18 genome. We used combinations of 
2 to 4 different restriction enzymes (Bpu1102I, PsyI, XmaJI, and CfrI) to digest 
the HPV genome at different regions (Ref. II, Fig. 5, genome animation). This 
kind of digestion results in four approximately 2 kbp fragments. As a result,  
we could separately analyze various regions, including a region containing  
the origin (CfrI-Bpu1102I, ORI probe), a region that excludes the origin 
(Bpu1102I-CfrI, TERM probe), a region containing E1 (Bpu1102I-PsyI, E1 
probe), a region excluding E1 (Psy-Bpu1102I, L1 probe), a region containing 
L1 (XmaJI-CfrI, L1 probe), a region excluding L1 (CfrI-XmaJI, E1 probe), a 
region containing the termination sequence (PsyI-XmaJI, TERM probe), and a 
region excluding termination (XmaJI-PsyI, ORI probe). 
While analyzing these ~2 kbp sub-genomic fragments, we found the classi-
cal theta replication RIs that we expected to find (Ref. II, Fig. 5, maller frag-
ments: Fig. 5A ORI probe, Fig. 5B TERM probe, Fig. 5C L1 probe, Fig. 5D E1 
probe). The region containing the origin (CfrI-Bpu1102I, ORI probe) yielded a 
bubble, simple Y, and dY structures. We observed simple Ys in both the E1 
(Bpu1102I-PsyI, E1 probe) and L1 regions (PsyI-XmaJI, L1 probe) and a 
simple Y and dY intermediate in the termination region (XmaJI-CfrI, TERM 
probe). Please refer to Ref. II, Fig. 5, smaller fragments: Fig. 5A ORI probe, 
Fig. 5B TERM probe, Fig. 5C L1 probe, and Fig. 5D E1 probe. The presence of 
dY intermediates in both the origin and termination regions confirms the 
phenomenon of having one active origin in an oligomer consisting of an even 
number of genomes. For example, bidirectional forks emerging from one origin 
of replication converge in the opposite site of origin, which in the case of a 
dimer would be the other origin of replication – possibly a passive origin. dY 
cannot originate from RIs from a novel replication mechanism because other-
wise dY RIs would also be present in both the E1 (Ref. II, Fig. 5D E1 probe) 
and the L1 regions (Ref. II, Fig. 5C L1 probe), which they are not. 
Coupled with every 2 kbp fragment, we also analyzed the rest of the HPV 
genome, excluding a 2 kbp sub-genomic fragment (in other words, ~6 kbp frag-
ments) (Ref. II, Fig. 5, larger fragments: Fig. 5A TERM probe, Fig. 5B ORI 
probe, Fig. 5C E1 probe, Fig. 5D L1 probe). However, while observing the 
larger fragments, we found the same pattern of novel intermediates that we 
found while analyzing the linearized full genome (Ref. II, compare Fig. 4A and 
Fig. 5 larger fragments, white bold arrows). We see arcs from RIs that originate 
from classical theta replication, including dYs in CfrI-Bpu1102I with TERM 
probe (Ref. II, Fig. 5A TERM probe, black bold arrow) and a bubble to dY 
transition in XmaJI-PsyI with ORI probe (Ref. II, Fig. 5B ORI probe, black 
bold arrow). However, the simple Ys on Bpu1102I-PsyI with the L1 probe and 
XmaJI-CfrI with the E1 probe coincide with the pattern of novel intermediates 
(Ref. II, Fig. 5C and 5D, larger fragments, white bold arrows). This result 
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confirms the presence of the simple Y in the arc of novel intermediates struc-
tures that we previously observed using 2D N/A (Ref. II, Fig. 4B and 4C). 
In summary, through the careful use of 2D N/N and N/A AGE, we obtained 
evidence of another genome replication method with unidirectional moving 
forks that operates in addition to the classical bidirectional theta type of HPV 
genome replication (Orav et al. 2015; Henno et al. 2017). We do not observe 
the involvement of RCR in any of the results we present here. It has been 
demonstrated that RCR intermediates form an eyebrow-shaped arc in uncut 
DNA analysis via 2D N/N GE (Belanger et al. 1996; Martin-Parras et al. 1998; 
Cohen et al. 2005), and our 2D assays do not display that kind of arc. Even 
though oligomers can be generated via either the RCR or RDR mechanisms, in 
our experiments, we observed intermolecular recombination of homologous 
sequences, and the only possible mechanism for generating hetero-oligomers 
could be through a HR-directed replication mode, excluding the possibility of 
RCR. However, RCR cannot be excluded entirely because oligomers consisting 
of a single molecular species could be obtained via the RCR mechanism.  
 
 
Novel replication mechanism 
Because many 2D analyses have previously been performed with PVs, there 
must have been some evidence of the novel mechanism, otherwise it would 
only be an artifact of our system. However, as mentioned above, analyzing sub-
genomic fragments of the HPV18 genome via 2D AGE provides a visualization 
of only common RIs, such as simple Y, dY, and bubble intermediates, because 
more complex structures have been digested into smaller and therefore less 
complex structures. Most of the 2D experiments performed with PVs analyze 
sub-genomic fragments of the full genome, and this approach explains why 
there is not much indication of RIs with extremely branched and complex struc-
tures (more complex than RIs originating from bidirectional theta replication). 
As described above, when we linearize the viral genome using a single cutter 
enzyme, we can visualize a much more complex replication pattern (Ref. II, 
Fig. 2–3). The results we obtain are difficult to interpret, which supports a mix-
ture of active replication mechanisms. 
Several works have indicated the presence of two different mechanisms 
during both stable maintenance and the second amplification phase of PV 
replication. There are some indications of intermediates from the novel mecha-
nism in addition to the well-known bidirectional theta replication mechanism 
published by Yang & Botchan and Flores & Lambert, who analyzed large sub-
genomic fragments of PV or the full-length PV genome, respectively (Yang and 
Botchan 1990; Flores and Lambert 1997). Yang & Botchan hypothesized that 
the 2D N/N AGE patterns obtained from BPV1 may represent a unidirectional 
replication mechanism. Flores & Lambert proposed that upon differentiation, 
both HPV16 and HPV31 begin to replicate their genomes via a unidirectional 
replication mode without a specific origin; however, they proposed RCR to be 
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that mode of replication (Flores and Lambert 1997). In addition, Flores & Lam-
bert analyzed a full HPV16 genome, and as they digested the DNA near the 
origin, they observed a strong spike emanating near 1n spot (signal is weak near 
1n) and proposed that it refers to dY intermediates of bidirectional replication, 
whereas I would propose that it resembles RIs from the novel mechanism. 
Therefore, I suggest that the difficult-to-interpret signals obtained from 2D as-
says originate from the novel replication mechanism and possibly may have 
been misinterpreted. 
The exact mechanism of how PVs manipulate and use HR pathways remains 
to be elucidated; however, it could be similar to the model proposed for circular 
dsDNA phage SPP1 (reviewed in (Lo Piano et al. 2011)) as proposed by 
(Sakakibara et al. 2013). SPP1 replicates bidirectionally until the replication 
forks are arrested, which leads to a DBR. The DBR is recognized by the host 
organism and induces the recruitment of host repair-related replisomal compo-
nents to the site. The repair machinery then generates a D-loop into which a new 
replisome is assembled. The D-loop forms a bubble that migrates unidirectional-
ly around the viral genome, thereby generating long concatemers. This step leads 
to a recombination dependent RCR-type of replication of SPP1 DNA. Thus, 
replication switches from the theta mode to recombination dependent RCR. 
However, aspects of this mechanism still require further confirmation. This kind 
of replication resembles the BIR mode of the HR mechanism, where ssDNA, 
which often originates from collapsed replication forks, invades dsDNA and 
forms a D-loop that migrates in a unidirectional fashion around the genome.  
However, none of the abovementioned mechanisms are identical to HPV 
replication, which is strongly dependent on the unique life cycle of differen-
tiating keratinocytes. Based on our results (Ref. I, Fig. 4E, Fig. 5B and Fig. 6), 
together with information gained from the work of (Fradet-Turcotte et al. 2011; 
Sakakibara et al. 2011; Gillespie et al. 2012; Reinson et al. 2013; Sakakibara et 
al. 2013; McKinney et al. 2015; Gautam and Moody 2016), we propose that HR 
and DDR are utilized by HPV DNA replication and that bidirectional and novel 
replication depend on each other. It is possible that the late theta intermediates 
that originate from bidirectional replication contain stalled replication forks. 
These collapsed forks give rise to double-stranded breaks that recruit factors of 
HR and DRR pathways and may trigger the novel replication mechanism. HPV 
replication, however, retains the ability to use both the bidirectional and RDR 
mode of replication during initial amplification in contrast with SSP1, where 
once the novel mechanism is triggered, it becomes the only mechanism used to 
replicate SPP1 genomes. 
 
 
Additional discussion and future perspectives 
Due to the complexity of the data we have collected, many patterns and features 
have yet to be confirmed. Future work should continue to study the mechanisms 
we propose here to add weight to or possibly refute our hypotheses. This work 
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can be achieved by analyzing the RIs via electron microscopy or atomic force 
microscopy; however, the best approach may be to improve the resolution of 
these images. Nevertheless, visual observation of the intermediates alone cannot 
identify the mechanism that HPV uses in addition to bidirectional theta replica-
tion. 
The mechanisms behind the creation of novel intermediates we observe can 
also be examined by knocking down/out the necessary proteins for cellular re-
pair and recombination and analyzing the resulting replication pattern obtained 
via 2D N/N AGE. However, we do not yet know for sure whether bidirectional 
and recombinational replication are dependent on each other and if there is even 
a possibility to separate those two replication mechanisms. 
We conclude from the data collected from experiments using 1D, 2D and 3D 
assays that HPV18 genomes utilize two different mechanisms for viral genome 
replication and therefore for the synthesis of oligomers. One is bidirectional 
theta replication, and the other is a separate novel mechanism. Our results indi-
cate that both mechanisms are used during the transient amplification phase. 
Bidirectional theta replication initiated from the previously identified origin of 
replication likely depends on the availability of viral replication factors E1 and 
E2. However, we propose that the novel replication mechanism may be con-
trolled by cellular factors. At this point, we can only suggest that the novel 
replication mechanism operates via a unidirectional mode.  
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CONCLUSIONS 
 High-risk HPV18 is capable of forming monomeric, dimeric and oligo-
meric molecules upon an initial establishment period (transient assay). 
 We characterized these oligomers as episomal head-to-tail concatemeric 
molecules. No other viral proteins, except for viral replication proteins E1 
and E2, are necessary for oligomer formation. Additionally, we can con-
clude that oligomer formation is a replication dependent process.  
 The phenomenon of oligomerization can occur in a region as small as the 
replication origin containing URR fragment of HPV18 when E1 and E2 are 
provided from expression vectors; thus, we can distinguish replication and 
oligomerization from transcription. 
 We conducted a complementation assay in which the complete HPV18 
genome is transfected into U2OS along with sub-genomic replicons. As a 
result, we detected joint molecules (hetero-oligomers) consisting of full-
length and sub-genomic HPV18 DNA. These experiments indicate that at 
least HPV genomic hetero-oligomers can arise through the homologous 
recombination step in replicating viral genomes; however, this step can 
also be the method of formation of homo-oligomers. 
 We propose that HPV18 genomes utilize at least two different mechanisms 
for viral genome replication during initial amplification: the replication 
intermediates that originate from bidirectional theta replication are appa-
rent in addition to uncertain structures originating from an undetermined 
replication mechanism that likely involves pathways of homologous 
recombination and DNA damage response.  
 We propose that the two mechanisms involved in HPV replication must 
therefore also participate in the formation of oligomers; however, the exact 
mechanisms of oligomer generation and resolvation into monomers must 
still be elucidated. 
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SUMMARY IN ESTONIAN 
Inimese papilloomiviiruse genoomi replikatsiooni ja  
oligomeeride tekke analüüs  
Papilloomiviirused (PV-d) on väikesed, ligikaudu 8000 aluspaari pikkused kahe-
ahelalise DNA genoomiga viirused, mis nakatavad kihistunud epiteeli basaalseid 
keratinotsüüte. PV-d on äärmiselt liigi- ja koespetsiifilised ja nad nakatavad ainult 
imetajate, lindude ja roomajate keratinotsüüte. Inimese papilloomiviirused (HPV-
d) on populatsioonis laialt levinud patogeenid, mille infektsiooniga kaasneb hea-
loomuliste vohandite tekkimine epiteelil (tüükad, papilloomid). Mõned HPV 
tüübid aga võivad põhjustada ka halvaloomuliste kasvajate teket. Inimese papil-
loomiviiruse poolt põhjustatud emakakaelavähk on kolmas enimlevinud vähk 
naistel, mistõttu selle valdkonna uuringud on väga olulised. 
Käesolevas töös leidis kasutust meie töögrupi poolt välja töötatud U2OS 
rakkudel põhinevat mudelsüsteemi, et uurida HPV18 genoomi lühiajalise repli-
katsiooni käigus tekkivaid viiruse genoomi oligomeere. Seda, et HPV moodus-
tab replikatsiooni käigus oligomeere, märgati juba üle 30 aasta tagasi, aga 
nende tekkepõhjuseid ei ole siiani välja selgitatud. Üks võimalik seletus, miks 
viiruse genoom esineb multimeerses vormis, on see, et HPV-de puhul kasuta-
takse ühe multimeeri paljundamiseks vaid ühte replikatsioonikompleksi (oligo-
meeris on aktiivne ainult üks replikatsiooni alguspunkt). Sellega kaasneb olu-
kord, et väheste peremeesraku ja viiruse valkudega saab paljundada suurt arvu 
HPV genoome. See võimaldab ära hoida või edasi lükata HPV tuvastamist pere-
meesraku immuunsüsteemi poolt.  
Selgitamaks välja oligomeeride tekkemehhanismi viisin läbi katse täispika ja 
subgenoomse HPV DNA-ga, mille tulemusena tekkisid hetero-oligomeerid 
(oligomeerid, mis koosnesid täispikast ja subgenoomsest HPV DNAst). Selline 
kahe eri molekuli vaheline kombineerumine saab toimuda ainult läbi homoloog-
se rekombinatsiooni radade ning üks võimalus HPV oligomeeride tekkeks ongi 
homoloogsel rekombinatsioonil põhinev DNA sünteesimehhanism. 
Töö üheks eesmärgiks oli läbi replikatsiooni vaheproduktide kirjeldamise 
uurida, mis mehhanisme kasutades HPV genoom replitseerub. Selle uurimise 
sobilikumaks meetodiks on kahedimensionaalne agaroos geelelektroforees (2D 
AGE). Tuvastasime, et lisaks varasemalt hästi kirjeldatud kahesuunalise theta 
replikatsiooni moodusele, esineb HPV-del ka teinegi siiani kirjeldamata repli-
katsioonimehhanism. Pakume, et teine replikatsioonimehhanism kasutab DNA 
kahjustuse radade (DDR) poolt rakendatavaid rakulisi valke ja faktoreid. Seda 
kinnitab ka asjaolu, et eelnevalt on näidatud DDR faktorite lokalisatsiooni HPV 
replikatsioonitsentritesse. 
Mitmedimensionaalseid geelelektroforeese on keerukas läbi viia, aga veelgi 
keerukam on tulemuste analüüs. Selle tõttu andsin käesolevas töös ka ülevaate, 
kuidas analüüsida ja tõlgendada kahe- ja kolmedimensionaalsest AGE-st saadud 
tulemusi. 
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Kokkuvõtvalt näitasin, et HPV kasutab genoomi paljundamiseks ja oligo-
meeride sünteesiks vähemalt kahte eri replikatsioonimehhanismi. Üks mehha-
nismidest on kahesuunaline theta replikatsiooni ja teine ühesuunaline homo-
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